You just read:

Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.

News provided by

Immune Therapeutics Inc.

May 04, 2015, 08:07 ET